Vanguard Advisers Inc’s Merck MRK Stock Holding History

Vanguard Advisers Inc’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45	Closed	-$5.41K	–	771
2026 Q1	$5.41K	Buy	+45	New	+$5.2K	﹤0.01%	420

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Advisers Inc's MRK Position: Q2 2026 in Review

Vanguard Advisers Inc sold out of Merck (MRK) in Q2 2026, closing a stake of 45 shares — an estimated $5.41K sold.

Vanguard Advisers Inc first reported a position in MRK in Q1 2026 and held it in 1 quarter. The position peaked at $5.41K in Q1 2026. 3,796 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Vanguard Advisers Inc reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
Vanguard Advisers Inc sold 45 Merck shares in Q2 2026, an estimated $5.41K.
Vanguard Advisers Inc first reported a position in Merck in Q1 2026 and held it in 1 quarter.
Vanguard Advisers Inc's Merck position peaked at $5.41K in Q1 2026.
3,796 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vanguard Advisers Inc's 13F filing for Q2 2026, filed 13 Aug 2026.